A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new ...
One woman's story of literal strength illustrates how ovarian cancer symptoms can be missed—and the lighthearted recovery ...
Ovarian cancer is the fifth leading cause of cancer-related deaths among women in the U.S. However, the racial bias makes it ...
A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...
Treatment with Rina-S showed antitumor activity in heavily pretreated patients with advanced ovarian cancer, according to the ...
There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...
A comparison of patients with and without BRCA gene mutations receiving prophylactic risk-reduction surgery suggest ...
When ovarian cancer moves beyond your ovaries or fallopian tubes, cancer cells may reach your liver, lungs, or other places in your body. The stage your doctor assigns to your ovarian cancer can ...
Nemvaleukin alfa is an investigational engineered fusion protein composed of modified interleukin-2 (IL-2) and the high-affinity IL-2 alpha receptor chain.
Started Two New Clinical Trials, Collaborating with MD Anderson and The Netherlands Cancer Institute for Treatment of Ovarian ...
New phase 3 data provide reassurance on safety, tolerability, and overall benefit-risk of mirvetuximab soravtansine (Elahere) ...
A new study finds that a common blood test for ovarian cancer may miss some Black and Native American patients, delaying ...